People v. Cancer

People v. Cancer

In the 2021 People v. Cancer summit, The Atlantic explored the latest science and the important ways in which prevention, diagnosis, treatment, and well-being are interrelated. Even in the midst of a global pandemic, progress continues to be made toward not only treating cancer and extending lives, but creating a more robust, holistic ecosystem of care.

We brought together medical providers, scientists, survivors, and patients for in-depth conversations about a disease that remains one of the world’s most complex, and most lethal. At People v. Cancer, The Atlantic explored the most crucial questions of the day: What is the future of cancer care? What can be done to improve lives for all—along the entire spectrum of care?

#PeopleVCancerWatch Now

Atlantic subscribers enjoy access to exclusive sessions and experiences.

Sign in or Subscribe
See All Speakers
  • Benjamin Creelan

    Thoracic Oncologist, H. Lee Moffitt Cancer Center

  • John Donvan

    Contributor, AtlanticLIVE

  • Martin Edelman

    Chair, Lung Cancer Foundation of America’s Scientific Advisory Board

  • Amanda R. Ferrero

    Survivor and Patient Advocate

  • Andrea Ferris

    President and CEO, LUNGevity Foundation

    Underwriter Session

  • Elizabeth Fox

    Senior Vice President, Clinical Trials Research, St. Jude Children’s Research Hospital

    Twitter
  • Ginger Gardner

    Vice Chair, Hospital Operations, Department of Surgery at Memorial Sloan Kettering Cancer Center and Chair, Foundation for Women’s Cancer

  • Patricia J. Goldsmith

    CEO, CancerCare

    Underwriter Session

  • James Hamblin

    Contributor, The Atlantic

    Twitter
  • Garret Hampton

    President, Clinical Next Generation Sequencing Division, Thermo Fisher Scientific

    Underwriter Session

  • Karen Knudsen

    President and CEO, The American Cancer Society (ACS) and The American Cancer Society Action Network (ACS CAN)

    Twitter
  • Christopher S. Lathan

    Chief Clinical Access and Equity Officer, Associate Medical Director, Dana-Farber Cancer Institute Network

    Twitter
  • Vincent Laudone

    Chief of Surgery, Josie Robertson Surgery Center, Memorial Sloan Kettering Cancer Center

  • Jeanne Meserve

    Contributor, AtlanticLIVE

    Twitter
  • Marleen Meyers

    Director of Cancer Survivorship, Perlmutter Cancer Center, NYU Langone

    Twitter
  • Candace Montgomery

    Senior Vice President and General Manager, AtlanticLIVE

  • Amanda Mull

    Staff Writer, The Atlantic

  • Jill O’Donnell-Tormey

    CEO and Director of Scientific Affairs, Cancer Research Institute

    Twitter
  • Solange Peters

    Centre Hospitalier Universitaire Vaudois (CHUV) Oncology Department, Lausanne, President of the European Society of Medical Oncology

    Underwriter Session

  • Alyx Porter

    Neurologist, Mayo Clinic and Author, Navigating Life with a Brain Tumor

    Twitter
  • Al Roker

    Weather and Feature Anchor, Today, and Co-host, Third Hour of Today

    Twitter
  • Nina Shah

    Professor of Clinical Medicine, Division of Hematology-Oncology, University of California San Francisco

    Underwriter Session

  • Padmanee Sharma

    Professor, Genitourinary Medical Oncology and Immunology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center

    Underwriter Session

  • Ned Sharpless

    Director, National Cancer Institute

    Twitter
  • Jonathan W. Simons

    Prostate Cancer Foundation Board of Directors, Medical Director and Chief Science Officer, Marcus Foundation

  • Luke Timmerman

    Founder and Editor, Timmerman Report

    Underwriter Session

  • Hayley Romer

    Publisher and Chief Revenue Officer, The Atlantic

    Underwriter Session

  • Andy Schmeltz

    Global President and General Manager, Pfizer Oncology

    Underwriter Session

  • Fyodor Urnov

    Professor, Molecular and Cell Biology Department, UC Berkeley and Scientific Director, Technology and Translation, Innovative Genomics Institute

    Underwriter Session

  • Christine Ward

    Vice President, Precision and Translational Medicine, Oncology Cell Therapy Therapeutic Area Unit, Takeda Oncology

    Underwriter Session

  • Tony Wood

    SVP Medicinal Science and Technology, GSK

    Underwriter Session

  • Sarah Zhang

    Staff Writer, The Atlantic

Welcome

11:00 am EDT
Virtual / In-Person

The War on Cancer, Revisited

Virtual / In-Person

Pfizer Presents: Bringing the Power of Collaboration to Health-care Delivery

Virtual / In-Person

The Frontlines of Research

Virtual / In-Person

GSK Presents: How Clues in our DNA are Uncovering New Opportunities to Advance Cancer Research

Virtual / In-Person

Screenings for All

Virtual / In-Person

Breakout Session - Bristol Myers Squibb Presents: The Future of Cancer Care: Transformative Innovation for All

Virtual / In-Person

Eliminating Prostate Cancer

Virtual / In-Person

A session produced by Astrazeneca

Virtual / In-Person

Why There’s No Cure for Brain Cancer, Yet

Virtual / In-Person

Breakout Session - GSK Presents: Exploring the Future of Immuno-Oncology (IO)

Virtual / In-Person

The Youngest Patients

Virtual / In-Person

New Innovations and the Future of Lung Cancer Care

Virtual / In-Person

Takeda Presents: The Future of Oncology: Precision Medicine and Comprehensive Diagnostic Testing

Virtual / In-Person

Finding Hope

Virtual / In-Person

Closing Remarks

3:55 pm EDT
Virtual / In-Person

Founding

Presenting

Event Details

Virtual Event

Tuesday, November 16, 2021

11:00 am EDT

Sponsorship

Underwriter Opportunities

jmj@theatlantic.com

Audience

Audience Engagement

events_audience@theatlantic.com

Speakers

Speaker Pitches

speakerpitches@theatlantic.com
See More Events